![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000047748 |
Receipt No. | R000054431 |
Scientific Title | Study on changes in blood glucose level by ingestion of dried banana powder |
Date of disclosure of the study information | 2022/05/13 |
Last modified on | 2022/05/13 |
Basic information | ||
Public title | Study on changes in blood glucose level by ingestion of dried banana powder | |
Acronym | Study on changes in blood glucose level by ingestion of dried banana powder | |
Scientific Title | Study on changes in blood glucose level by ingestion of dried banana powder | |
Scientific Title:Acronym | Study on changes in blood glucose level by ingestion of dried banana powder | |
Region |
|
Condition | ||
Condition | Healthy Adults | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To examine the effect of 8-week continuous ingestion of dried banana powder on fasting blood glucose levels and the effect of an acute ingestion of dried banana powder on postprandial blood glucose levels in 20 to 50 years old adults. |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Fasting blood glucose levels
HbA1c |
Key secondary outcomes | Postprandial blood glucose levels (delta AUC, delta Cmax, delta C, Tmax
Fasting insulin levels Anthropometric measurements (body mass and BMI) Feelings of fullness (fullness, hunger, satisfaction, appetite score) Defecation condition (frequency, amount, stool form, smell, feeling of exhilaration) |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Double blind -all involved are blinded |
Control | Placebo |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | Ingest test food A (25g dried banana powder) and carbohydrate tolerance foods on a single day for an acute trial and ingest test food A daily for 8 weeks for a chronic trial | |
Interventions/Control_2 | Ingest test food B (21.2g starch and sucrose mixed powder) and carbohydrate tolerance foods on a single day for an acute trial and ingest test food B daily for 8 weeks for a chronic trial | |
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 1.Persons who provide written informed consent to participate in this study
2.Japanese men and women who are between 20 and 50 years old 3.Persons who have less than 126 mg/dL of fasting blood glucose 4.Persons who have no glucose intolerance within the past year (persons who have never been diagnosed or indicated as diabetes or pre-diabetes) 5.Persons who meet the above criteria with a fasting blood glucose level in the top 60 |
|||
Key exclusion criteria | 1.Persons who have BMI of less than 18 kg/m2 or more than 30 kg/m2
2.Persons who have any chronic illnesses with medication and who have any serious disease histories 3.Persons who have any allergies to the ingredients used in the test food or dairy products 4.Persons who regularly take large amounts of the test food 5.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect blood glucose level 6.Persons who have participated in other tests within the past one month before the start of test, or those who intend to participate in another exam after consenting to the exam 7.Persons who were judged as inappropriate for study participant by the principal investigator 8.Persons who are breast-feeding, pregnant and planning or wishing to become pregnant during the study period |
|||
Target sample size | 60 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Healthcare Systems Co., Ltd. | ||||||
Division name | Clinical Research Department | ||||||
Zip code | 105-0004 | ||||||
Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
TEL | 03-6809-2722 | ||||||
asahina.yuki@hc-sys.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Healthcare Systems Co., Ltd. | ||||||
Division name | Clinical Research Department | ||||||
Zip code | 105-0004 | ||||||
Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
TEL | 03-6809-2722 | ||||||
Homepage URL | |||||||
asahina.yuki@hc-sys.jp |
Sponsor | |
Institute | Healthcare Systems Co., Ltd. |
Institute | |
Department |
Funding Source | |
Organization | SOLROS Co., Ltd. |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
Tel | 03-6809-2722 |
soumu@hc-sys.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054431 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |